← SynDRA
QX-222
SynDRA canonical compound SYN0079324 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Mechanism of action | sodium channel blocker |
Mechanisms of action (all sources)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- RefChem:178401
- [2-(2,6-dimethylanilino)-2-oxoethyl]-trimethylazanium
- Tocris-1043
- Lopac-L-1788
- Lopac0_000707
- SCHEMBL94463
- CHEBI:92720
- CCG-204792
- NCGC00015597-01
- NCGC00015597-02
- NCGC00015597-03
- NCGC00024960-01
- NCGC00024960-02
- BRD-K40782193-003-01-1
- BRD-K40782193-003-02-9
- [2-(2,6-dimethylanilino)-2-oxoethyl]-trimethylammonium
- MS-23617
- SCHEMBL7704273
- HY-101362
- QX222
- AKOS024456346
- CS-0021219
- orb1305695
- EU-0100707
- G68178
- SR-01000075956
- FAA36900
- QX-222 (chloride)
- qx-222 chloride
- HMS3412C05
- T23213
- SR-01000075956-3
- HMS3676C05
- DA-67082
- NCGC00094058-01
- SR-01000075956-1
- Lidocaine N-methyl hydrochloride
- HMS3267A22
Look up QX-222 in the interactive SynDRA portal →